Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating Activities
Net loss	$ (3,311)	$ (5,996)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	62,266	65,596
Loss on disposal of assets	412	2,110
Share-based compensation expense	30,277	43,113
Deferred income taxes	(9,401)	(14,165)
Amortization of operating lease right-of-use assets	5,279	6,238
Impairment and abandonment of operating lease right-of-use assets related to facilities	0	7,815
Inventory write-down	5,393	0
Amortization of debt issuance costs	2,917	3,139
Changes in operating assets and liabilities:
Accounts receivable and unbilled receivables	1,174	27,050
Inventories	10,038	31,690
Prepaid expenses	(2,918)	(857)
Other current assets	8,354	1,521
Investment in sales-type leases	(7,453)	(8,839)
Prepaid commissions	2,684	5,533
Other long-term assets	1,048	2,539
Accounts payable	2,945	(13,358)
Accrued compensation	(6,664)	(29,390)
Accrued liabilities	6,963	3,749
Deferred revenues	27,746	23,628
Operating lease liabilities	(8,021)	(8,145)
Other long-term liabilities	1,679	(291)
Net cash provided by operating activities	131,407	142,680
Investing Activities
External-use software development costs	(11,849)	(10,240)
Purchases of property and equipment	(27,376)	(32,404)
Net cash used in investing activities	(39,225)	(42,644)
Financing Activities
Proceeds from issuances under stock-based compensation plans	13,140	23,035
Employees’ taxes paid related to restricted stock units	(3,544)	(6,130)
Change in customer funds, net	(10,744)	(6,615)
Net cash provided by (used in) financing activities	(1,148)	10,290
Effect of exchange rate changes on cash and cash equivalents	879	(464)
Net increase in cash, cash equivalents, and restricted cash	91,913	109,862
Cash, cash equivalents, and restricted cash at beginning of period	500,979	352,835
Cash, cash equivalents, and restricted cash at end of period	592,892	462,697
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	570,628	446,840
Restricted cash included in other current assets	22,264	15,857
Cash, cash equivalents, and restricted cash at end of period	592,892	462,697
Supplemental disclosure of non-cash investing activities
Unpaid purchases of property and equipment	$ 432	$ 642